MoonLake Immunotherapeutics
MLTXPharmaceutical Preparations · SIC 2834 · CIK 0001821586
Revenue FY2025
—
Net Income
$(227.0M)
EPS (Basic)
$-3.53
Net Margin
—
ROE
-74.7%
Total Equity
$304.0M
Shares Out
85M
MoonLake Immunotherapeutics — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 3 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Vivo Capital
Vivo Capital
$27.3M
0.4%
+40.0%
Renaissance Technologies
Renaissance Technologies
$12.5M
0.0%
+132.4%
Holocene Advisors
Holocene Advisors
$4.9M
0.0%
(58.3%)
Insider Transactions
Reading stored insider transactions…